Page 106 - 73_02

HERBERT ZIMMERMANN Y COLS. AN. R. ACAD. NAC. FARM.

(98) SUN, L.; IGBAL, J.; DOLGILEVICH, S.; YUEN, T.; WU, X. B.; MOONGA, B. S.;
ADEBANJO, O. A.; BEVIS, P. J.; LUND, F.; HUANG, C. L.; BLAIR, H. C.; ABE, E. and
(99) ZAIDI, M. (2003): Disordered osteoclast formation and function in a CD38
(ADP-ribosyl cyclase)-defocoent mouse establishes an essential role for CD38
(100) in bone resorption. FASEB J. 17: 369-375.
(101) ITOH, M.; ISHIHARA, K.; HIROI, T.; LEE, B. O.; MAEDA, H.; IIJIMA, H.; YANAGITA,
(102) M.; KIYONO, H. and HIRANO, T. (1998): Deletion of bone marrow stromal
(103) antigen-1 (CD157) gene impaired systemic thymus independent-2 antigen-
(104) induced IgG3 and mucosal TD antigen-elicited IgA responses. J. Immunol.
(105) 161: 3974-3983.
(106) SALMI, M. and JALKANEN, S. (2005): Cell-surface enzymes in control of
(107) leukocyte trafficking. Nature Rev. Immunol. 5: 760-771.
(108) BURCH, L. H. and PICHER, M. (2006): E-NTPDases in human airways
regulation and relevance for chronic lung diseases. Purinergic Signalling. 2:
(109) 399-408.
VLAJKOVIC, S. M.; VINAYAGA-MOORTHY, A.; THORNE, P. R.; ROBSON, S. C.; WANG,
C. J. H. and HOUSLEY, G. D. (2006): Noise-induced up-regulation of NTPDase3
expression in the rat cochlea: Implications for auditory transmission and
cochlear protection. Brain Res. 1104: 55-63.
GENDRON, F. P.; BENREZZAK, O.; KRUGH, B. W.; KONG, Q.; WEISMAN, G. A. and
BEAUDOIN, A. R. (2002): Purine signaling and potential new therapeutic
approach: Possible outcome of NTPDase inhibition. Current Drug Targets.
3: 229-245.
KENNEDY, C.; WESTFALL, T. D. and SNEDDON, P. (1996): Modulation of
purinergic neurotransmission by ecto-ATPase. Semin. Neurosci. 8: 195-199.
WESTFALL, T. D.; KENNEDY, C. and SNEDDON, P. (1997): The ecto-ATPase
inhibitor ARL 67156 enhances parasympathetic neurotransmission in the
guinea-pig urinary bladder. Eur. J. Pharmacol. 329: 169-173.
DRAKULICH, D. A.; SPELLMON, C. and HEXUM, T. D. (2004): Effect of the ecto-
ATPase inhibitor, ARL 67156, on the bovine chromaffin cell response to
ATP. Eur. J. Pharmacol. 485: 137-140.
GENDRON, F. P.; HALBFINGER, E.; FISCHER, B.; DUVAL, M.; D’ORLÉANS-JUSTE, P.
and BEAUDOIN, A. R. (2000): Novel inhibitors of nucleoside triphosphate
diphosphohydrolases: Chemical synthesis and biochemical and
pharmacological characterizations. J. Med. Chem. 43: 2239-2247.
IQBAL, J.; VOLLMAYER, P.; BRAUN, N.; ZIMMERMANN, H. and MÜLLER, C. E.
(2005): A capillary electrophoresis method for the characterization of ecto-
nucleoside triphosphate diphosphohydrolases (NTPDases) and the screening
of inhibitors by in-caplllary enzymatic microreactions. Purinergic Signalling.
1: 349-358.
MÜLLER, C. E.; IQBAL, J.; BAQI, Y.; ZIMMERMANN, H.; RÖLLICH, A. and STEPHAN, H.
(2006) Polyoxometalates - a new class of potent ecto-nucleoside triphosphate
diphosphohydrolase (NTPDase) inhibitors. Biorog. Med. Chem. Lett. 16: 5943-
5947.

564